Metro Healthcare Indonesia Tbk PT
IDX:CARE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
75
193
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Metro Healthcare Indonesia Tbk PT
Metro Healthcare Indonesia Tbk PT
Free Cash Flow
Metro Healthcare Indonesia Tbk PT
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Metro Healthcare Indonesia Tbk PT
IDX:CARE
|
Free Cash Flow
-Rp95.6B
|
CAGR 3-Years
41%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Siloam International Hospitals Tbk PT
IDX:SILO
|
Free Cash Flow
Rp735.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medikaloka Hermina Tbk PT
IDX:HEAL
|
Free Cash Flow
-Rp974B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
Free Cash Flow
-Rp345.7B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-11%
|
|
|
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
|
Free Cash Flow
Rp1.3T
|
CAGR 3-Years
13%
|
CAGR 5-Years
24%
|
CAGR 10-Years
18%
|
|
|
F
|
Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
|
Free Cash Flow
-Rp271.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Metro Healthcare Indonesia Tbk PT
Glance View
PT Metro Healthcare Indonesia Tbk engages in the provision of integrated healthcare services. The company is headquartered in Tangerang, Banten and currently employs 713 full-time employees. The company went IPO on 2020-03-13. The firm operates its business in an integrated health service with hospital under Metro Hospital Group. The company is focused on developing technology-based health services and training centers to produce professionals in health services. The firm offers healthcare service with a range of services and facilities including polyclinic, ICU room, class III inpatient room and Super VIP room ready to cater various type of patients. The firm operates RSIA Bunda Sejahtera, RSU Bina Sehat Mandiri, RSU Metro Hospitals Cikarang, RSU Metro Hospitals Cikupa, RSU Kartini, RSIA Mitra Husada, and RSIA Santo Yusuf. Its subsidiaries include PT Metro Global Medika, PT Metro Healthcare Technologies, PT Metro Medika Abadi, PT Mitra Adika Buana, PT Metro Hospitals Indonesia, PT Metro Mitra Sarana, PT Eka Tunggal Jaya, PT Paramudya Dasa Sakti, PT Indah Nusa Indonesia, PT Sejahtera Berkah Berdikari, and PT Berkarya Sejahtera Gemilang.
See Also
What is Metro Healthcare Indonesia Tbk PT's Free Cash Flow?
Free Cash Flow
-95.6B
IDR
Based on the financial report for Dec 31, 2023, Metro Healthcare Indonesia Tbk PT's Free Cash Flow amounts to -95.6B IDR.
What is Metro Healthcare Indonesia Tbk PT's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
17%
Over the last year, the Free Cash Flow growth was 72%. The average annual Free Cash Flow growth rates for Metro Healthcare Indonesia Tbk PT have been 41% over the past three years , 17% over the past five years .
You don't have any saved screeners yet
